Francesca Fornari

19PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 27, 2026
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.

|May 07, 2025
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma.

Ilaria Leoni, Giuseppe Galvani, Elisa Monti

|Jan 24, 2025
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies.

Elisa Monti, Clara Vianello, Ilaria Leoni

|Feb 24, 2024
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response.

Clara Vianello, Elisa Monti, Ilaria Leoni

|Jun 10, 2023
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma.

Christian Bergamini, Ilaria Leoni, Nicola Rizzardi

|Mar 29, 2023
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma.

Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli

Pageof 4

Frequent Collaborators

10 joint publications

Fabio Piscaglia

9 joint publications

Catia Giovannini

7 joint publications

Laura Gramantieri

4 joint publications

Elisa Monti